- Dr. Zaghloul Ahmed, The City University of New York: a treatment using electrical stimulation that could help the wheelchair-bound to walk. Mentored by Frank DeBernardis of Nascent Enterprises.
- Dr. Michelle Bradbury, Memorial Sloan-Kettering Cancer Center: a process that uses a silica nanoparticle and hand-held imaging tools to improve detection of cancer cells in lymph nodes of metastatic melanoma patients. This nanoparticle has been FDA IND approved. Such an approach would allow doctors to identify and treat cancer earlier. Mentored by Jerry Korten, the former CEO of Versamed.
- Dr. Anne Bresnick, Albert Einstein College of Medicine, Yeshiva University: a treatment to improve the cancer survival rate of patients by preventing the disease from spreading to disparate locations in the body. The treatment would focus on the S100 family of calcium-binding proteins, which are involved in tumor metastasis. Mentored by Linda Hogan of Care Capital. READ MORE »
- Dr. Ramanuj Dasgupta, NYU School of Medicine: Dr. Dasgupta is developing a new treatment that could reduce the side effects of certain existing cancer drugs. Dr. Dasgupta has developed a way to target a specific region on select molecules to make them more accessible to cancer inhibitors, without the side effects that have plagued other similar drugs. The BioAccelerate funds will be used to test some of the identified compounds for their suitability in the treatment. Dr. Dasgupta is being mentored by Edward Garmey, the Chief Medical Officer of Cerulean Pharmaceuticals.
- Dr. Kalle Levon, Polytechnic Institute of New York University: a hand-held device that would test for infectious diseases using minute quantities of samples from patients. Mentored by David Shaw of Black Point Group.
- Dr. Chuanju Liu, NYU School of Medicine: a potentially safer and more effective drug treatment for patients suffering from chronic autoimmune diseases. Many of these patients are on a lifelong drug regimen that can have damaging side effects. Mentored by Donald Drakeman of Advent Venture Partners and Annarie Lyles of Genmab, Inc.
- Dr. Suzanne Maher, Hospital for Special Surgery: Dr. Maher is developing an implant to treat and halt the progression of osteoarthritis, a condition in which the cartilage in your joints deteriorates. The BioAccelerate funds will enable Dr. Maher and her team to further test the implants before they can be tested in humans. Dr. Maher’s mentor is Mr. Frank DeBernardis, founder/CEO of Nascent Ventures.
- Dr. Sheila Nirenberg, Weill Cornell Medical College: a new device for treating blindness caused by retinal-degeneration. The research uses technology that has the capacity to bring back near-normal vision. Mentored by Dr. Milena Adamian, Director of the Life Science Angels.
- Dr. Michael Ohlmeyer, Mount Sinai School of Medicine: Dr. Ohlmeyer is working on adapting a gene called FOX-1, which functions as a tumor suppressor. In certain very aggressive cancers such as breast and ovarian, the FOX-1 protein is unable to naturally suppress tumors. Dr. Ohlmeyer and his team have identified a number of compounds that can assist FOX-1 to better resist aggressive cancers and utilize its tumor suppressing function in cells. Dr. Ohlmeyer and his team are being mentored by Dr. Laura Philips, a board member at Delcath Systems.
- Dr. Mark Philips, NYU School of Medicine: a treatment that aims to block one of the most potent cancer molecules. Mentored by Colin Freund of Agennix.
- Dr. Brent Stockwell, Columbia University: a new class of drugs to treat cancer in a more selective and non-toxic way by targeting proteins. Such an approach could potentially enable the treatment of chemotherapy-resistant tumors. Mentored by Edward Garmey of ArQule, Inc. READ MORE »
- Dr. Alexander Travis, Cornell University: Dr. Travis and his colleagues at the Baker Institute and Weill Cornell Medical College have developed a diagnostic test to determine male fertility. The test will help couples contemplating costly fertility treatments determine whether certain treatments may be beneficial. Results from this test would enable clinicians to counsel patients toward an appropriate fertility treatment, sparing them the enormous physical, emotional and financial costs associated with failed treatment cycles. BioAccelerate funds will be used for clinical studies at Weill Cornell Medical College. Dr. Travis has been mentored by Mr. Jerry Korten, former CEO of Versamed, a company he sold to General Electric.
- Dr. Gordana Vunjak-Novakovic, Columbia University: a breakthrough for those suffering the physical and psychological scars of damaged bones of the head and face, with a focus on the jaw area. The project involves growing viable, anatomically-shaped bone grafts in a laboratory and using them to re-build the patient’s bone structures. Mentored by Melanie Rolli of Novartis.
- Dr. Judah Weinberger, Columbia University: a device that would regulate blood flow from the artery to the vein to make dialysis safer for patients with kidney failure. The device could reduce distal hand atrophy and high output heart failure. Mentored by Arikha Moses of the Vertical Group.
- Dr. Howard Worman, Columbia University: a treatment for patients suffering from cardiomyopathy, a deterioration of the heart muscle, that would use drugs currently used to treat cancer. Mentored by Christian Kopfli of Chromocell.